Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v10-EN
Language English English
Date Updated 2019-03-26 2019-02-19
Drug Identification Number 02444852 02444852
Brand name BASAGLAR BASAGLAR
Common or Proper name insulin glargine (rDNA origin) insulin glargine (rDNA origin)
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients INSULIN GLARGINE INSULIN GLARGINE
Strength(s) 100UNIT 100UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size KwikPen, 3 mL prefilled pen, in packages of 5 KwikPen, 3 mL prefilled pen, in packages of 5
ATC code A10AE A10AE
ATC description INSULINS AND ANALOGUES INSULINS AND ANALOGUES
Reason for discontinuation Other (Please describe in comments) Other (Please describe in comments)
Anticipated discontinuation date 2019-08-30 2019-03-29
Actual discontinuation date
Remaining supply date 2019-08-30 2019-03-29
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments The Basaglar KWIKPEN DIN 02444852 which delivers up to 60 UNITS PER INJECTION DELIVERY is being discontinued and replaced by the Basaglar KWIKPEN DIN 02461528 which DELIVERS UP TO 80 UNITS PER INJECTION. The Basaglar KWIKPEN DIN 02444852 which delivers up to 60 UNITS PER INJECTION DELIVERY is being discontinued and replaced by the Basaglar KWIKPEN DIN 02461528 which DELIVERS UP TO 80 UNITS PER INJECTION.
Health Canada comments